TR200200738T2 - Therapeutic removal of endometrial tissue outside the uterus, chronic lower abdominal pain and fallopian tube obstruction. - Google Patents

Therapeutic removal of endometrial tissue outside the uterus, chronic lower abdominal pain and fallopian tube obstruction.

Info

Publication number
TR200200738T2
TR200200738T2 TR2002/00738T TR200200738T TR200200738T2 TR 200200738 T2 TR200200738 T2 TR 200200738T2 TR 2002/00738 T TR2002/00738 T TR 2002/00738T TR 200200738 T TR200200738 T TR 200200738T TR 200200738 T2 TR200200738 T2 TR 200200738T2
Authority
TR
Turkey
Prior art keywords
abdominal pain
fallopian tube
uterus
lower abdominal
endometrial tissue
Prior art date
Application number
TR2002/00738T
Other languages
Turkish (tr)
Inventor
Engel Jurgen
Rieth-Muller-Winzen Hilde
Felberbaum Ricardo
Diedrich Klaus
K�Pker Wolfgang
Original Assignee
Zentaris Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Ag filed Critical Zentaris Ag
Publication of TR200200738T2 publication Critical patent/TR200200738T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Mevcut bulus LHRH antagonistinin kisa süreli indükleme tedavisi ile yaklasik 4 ila 12 haftalik bir süre boyunca endometriyal dokunun rahim disi çogalmasi, kronik alt karin agrisi ve fallop tüpü tikanikliginin terapötik olarak giderilmesi için bir yöntem saglar.The present invention provides a method for therapeutic elimination of endometrial tissue prosthesis, chronic lower abdominal pain, and fallopian tube blockage for a period of approximately 4 to 12 weeks with short-term induction therapy of the LHRH antagonist.

TR2002/00738T 1999-09-23 2000-09-20 Therapeutic removal of endometrial tissue outside the uterus, chronic lower abdominal pain and fallopian tube obstruction. TR200200738T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15547899P 1999-09-23 1999-09-23

Publications (1)

Publication Number Publication Date
TR200200738T2 true TR200200738T2 (en) 2002-08-21

Family

ID=22555601

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/00738T TR200200738T2 (en) 1999-09-23 2000-09-20 Therapeutic removal of endometrial tissue outside the uterus, chronic lower abdominal pain and fallopian tube obstruction.

Country Status (22)

Country Link
EP (1) EP1214086A2 (en)
JP (2) JP2003509467A (en)
KR (1) KR100772852B1 (en)
CN (2) CN1376070A (en)
AU (1) AU769482B2 (en)
BG (1) BG66128B1 (en)
BR (1) BR0014198A (en)
CA (1) CA2383510A1 (en)
HK (1) HK1049117A1 (en)
HU (1) HUP0202741A3 (en)
IL (1) IL148185A0 (en)
MX (1) MXPA02002436A (en)
NO (1) NO331198B1 (en)
NZ (1) NZ534836A (en)
PL (1) PL201898B1 (en)
RU (1) RU2255759C2 (en)
SK (1) SK3752002A3 (en)
TR (1) TR200200738T2 (en)
TW (1) TWI267373B (en)
UA (1) UA73956C2 (en)
WO (1) WO2001021194A2 (en)
ZA (1) ZA200201374B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10157628A1 (en) * 2001-11-26 2003-06-12 Zentaris Ag Solution for injection of an LHRH antagonist
US7214662B2 (en) 2001-11-27 2007-05-08 Zentaris Gmbh Injectable solution of an LHRH antagonist
WO2009094634A1 (en) 2008-01-24 2009-07-30 Esperance Pharmaceuticals Lytic domain fusion constructs and methods of making and using same
CA2750582A1 (en) * 2009-01-22 2010-07-29 Maatschap Interne Geneeskunde Rijnstate Method for the prophylaxis or treatment of flushing
KR20210090298A (en) 2012-10-30 2021-07-19 에스퍼란스 파마슈티컬스, 인코포레이티드 Antibody/drug conjugates and methods of use
EP4223298A3 (en) 2013-03-15 2023-08-16 AbbVie Inc. Compositions for use in treating heavy menstrual bleeding
SG11202001436YA (en) 2017-08-18 2020-03-30 Abbvie Inc Pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis
TW201912157A (en) 2017-08-18 2019-04-01 美商艾伯維有限公司 Solid pharmaceutical formulation for the treatment of endometriosis, uterine fibroids, polycystic ovary syndrome and adenomyosis
US11690854B2 (en) 2018-04-19 2023-07-04 Abbvie Inc. Methods of treating heavy menstrual bleeding
EP3560555A1 (en) 2018-04-26 2019-10-30 LifeArc A composition for treating one or more estrogen related diseases

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5064939A (en) * 1990-02-06 1991-11-12 The Salk Institute For Biological Studies Cyclic gnrh antagonists
SE9301606D0 (en) * 1993-05-07 1993-05-07 Per-Christer Oden COMPOSITION FOR THE TREATMENT OF IMPAIRED HAIR GROWTH
US5658884A (en) * 1994-07-22 1997-08-19 The Medical College Of Hampton Roads Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
WO1996003138A1 (en) * 1994-07-22 1996-02-08 The Medical College Of Hampton Roads Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
DE19513662A1 (en) * 1995-04-08 1996-10-10 Schering Ag Combined pharmaceutical preparation for hormonal contraception
DE19604231A1 (en) * 1996-01-29 1997-07-31 Schering Ag Combined pharmaceutical preparation and its use for the treatment of gynecological disorders
RU2108583C1 (en) * 1996-07-29 1998-04-10 Николай Владимирович Рымашевский Method for determining indications to applying hormone therapy in genital endometriosis patients
CN1228708A (en) * 1996-09-04 1999-09-15 有限会社多特 Peptide-containing drug compositions for oral administration
EP0986550A1 (en) * 1997-06-05 2000-03-22 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
DE19911771B4 (en) * 1999-03-17 2006-03-30 Zentaris Gmbh LHRH antagonist, process for its preparation and its use

Also Published As

Publication number Publication date
KR100772852B1 (en) 2007-11-02
CA2383510A1 (en) 2001-03-29
NO331198B1 (en) 2011-10-31
JP2012051920A (en) 2012-03-15
NZ534836A (en) 2007-07-27
HUP0202741A3 (en) 2003-12-29
PL201898B1 (en) 2009-05-29
KR20020035879A (en) 2002-05-15
JP2003509467A (en) 2003-03-11
IL148185A0 (en) 2002-09-12
AU7779200A (en) 2001-04-24
NO20021430D0 (en) 2002-03-21
PL353244A1 (en) 2003-11-03
BG106584A (en) 2003-02-28
CN1376070A (en) 2002-10-23
SK3752002A3 (en) 2003-06-03
WO2001021194A3 (en) 2002-03-14
EP1214086A2 (en) 2002-06-19
TWI267373B (en) 2006-12-01
ZA200201374B (en) 2002-10-30
WO2001021194A2 (en) 2001-03-29
BR0014198A (en) 2002-05-21
MXPA02002436A (en) 2003-02-12
UA73956C2 (en) 2005-10-17
BG66128B1 (en) 2011-06-30
AU769482B2 (en) 2004-01-29
HK1049117A1 (en) 2003-05-02
NO20021430L (en) 2002-05-07
RU2255759C2 (en) 2005-07-10
HUP0202741A2 (en) 2003-01-28
CN101045155A (en) 2007-10-03

Similar Documents

Publication Publication Date Title
BR0015284A (en) Controlled Release Hydrocodone Formulations
PL366430A1 (en) Sustained release formulations of oxymorphone
DK0893998T3 (en) Delivery of nicotine into the large intestine for the treatment of inflammatory bowel diseases
ATE283700T1 (en) THERAPEUTIC USE OF A HEDGEHOG SIGNAL TRANSMISSION PATHWAY INHIBITOR
CY1106763T1 (en) PREVENTIVE OR THERAPEUTIC MEANS FOR INFLAMMATORY BOWEL DISEASES
NZ517039A (en) Intravaginal clindamycin ovule composition, where the clindamycin is dispersed in a hard fat suppository base
NO20014519L (en) Apomorphine and Sildenafil Preparation
DK0998287T3 (en) Use of levobupivacaine
BR0010869A (en) Method for administering a corticosteroid to a posterior segment of an eye and implantable sustained release device
HRP20020837B1 (en) HORMON COMPENSATION TREATMENT
BR0014996A (en) Method for preventing or ameliorating pain from a surgically closed wound in an individual, and, plaster
BE2012C040I2 (en)
ATE320796T1 (en) PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF ANAL INCONTINENCE AND ANAL ITCHING
SE0002754D0 (en) New pharmaceutical combination formulation and method of treatment with the combination
AU4063601A (en) Use of il-18 inhibitors
WO2001021194A3 (en) Method for the therapeutic management of endometriosis and fallopian tube obstruction
ATE297732T1 (en) COMBINATION THERAPY FOR THE TREATMENT OF HEART FAILURE
CA2416879A1 (en) Methods of treating cancer and the pain associated therewith using endothelin antagonists
GEP201606538B (en) Preoperative treatment of post operative pain
SE9904424D0 (en) Use of interleukin-6 in combination with leptin in the treatment of obesity
EP1347754A4 (en) Compositions for adhesion prevention
Gîscǎ et al. Scrotal urethrostomy in the dog-operating technique.
GR1003588B (en) Wheelchair of multiple use
EP1385497A4 (en) METHOD FOR PREVENTING OR TREATING BREAST CANCER, PROSTATE AND / OR COLUMN OF UTERUS USING N, N-DIMETHYLGLYCIN